In middle-aged women, visceral fat, more commonly called belly fat, is known to be a significant risk factor for cardiovascular disease, but what causes visceral fat to accumulate? The culprit is likely not age, as is commonly believed, but the change in hormone balance that occurs during the menopause transition, according to researchers at Rush University Medical Center. "Of all the factors we analyzed that could possibly account for the increase in visceral fat during this period in a woman's lifetime, levels of active testosterone proved to be the one most closely linked with abdominal fat, " said Imke Janssen, PhD, assistant professor of preventive medicine and the study's lead investigator.
For many women, the word " menopause " means living with innumerable symptoms which can alter the course of their lives. Menopause affects nearly 40 million women in the United States and while it is a natural time of physical and emotional change, it can also be a time of confusion and worry. Common symptoms include hot flashes, night sweats, insomnia, irritability, low libido, and depression. Hot Flashes are the most common symptom experienced by menopausal women. ChiliPad™ , a revolutionary mattress pad with both heating and cooling functions, reduces the severity of hot flashes by allowing consumers to adjust the entire surface of their bed to the desired temperature.
Women who have premature menopause because of medical interventions are at an increased risk of developing lung cancer, according to a new study published in the International Journal of Cancer. The startling link was made by epidemiologists from the Universit√ de Montr√ al, the Research Centre of the Centre Hospitalier de l'Universit√ de Montr√ al and the INRS - Institut Armand-Frappier. "We found that women who experienced non-natural menopause are at almost twice the risk of developing lung cancer compared to women who experienced natural menopause, " says Anita Koushik, a researcher at the Universit√ de Montr√ al's Department of Social and Preventive Medicine and a scientist at the Research Centre of the Centre Hospitalier de l'Universit√ de Montr√ al.
New results show that postmenopausal women with breast cancer receiving adjuvant letrozole have better cognitive function than women being treated with tamoxifen. The data, from a recent meeting of the American Society of Clinical Oncology (ASCO), are drawn from a sub-study of the Breast International Group (BIG) 1-98 trial. The trial, which enrolled postmenopausal women surgically treated for early-stage, hormone-responsive breast cancer, found that letrozole was more effective at preventing recurrent disease (especially distant metastases) than tamoxifen. Karen E. Ribi, PhD, with the International Breast Cancer Study Group in Bern, Switzerland, and her colleagues had theorized that because of the estrogen deprivation associated with aromatase inhibitors, patients who have received letrozole will have worse cognitive function than tamoxifen-treated patients.
Researchers studying a large population of women in Denmark found that those who took hormone replacement therapy (HRT) after menopause had a significantly higher risk of developing ovarian cancer than those who did not. However, one independent expert suggested the findings don't prove that HRT causes ovarian cancer and aren't clear enough to help women weigh up the pros and cons of going on HRT. The study was the work of first author Lina Steinrud Morch of Copenhagen University and colleagues and is published in the 15 July issue of the Journal of the American Medical Association, JAMA. While other studies have suggested a link between ovarian cancer and postmenopausal hormone therapy, they don't reveal how this might depend on the type, dose and duration of therapy, wrote the researchers.
Breast Cancer Risk In Postmenopausal Women Exposed To Hormone Replacement Therapy, Could Be Reduced By Asian Spice
Previous studies have found that postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy have increased their risk of developing progestin-accelerated breast tumors. Now, University of Missouri researchers have found that curcumin, a popular Indian spice derived from the turmeric root, could reduce the cancer risk for women after exposure to hormone replacement therapy. "Approximately 6 million women in the United States use hormone replacement therapy to treat the symptoms of menopause, " said Salman Hyder, the Zalk Endowed Professorship in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center.